Vetter Expands Filling Capacity - - BioPharm International

ADVERTISEMENT

Vetter Expands Filling Capacity



The CDMO Vetter is investing more than $100 million across its production sites in Germany and the United States to expanding and upgrading its facilities to expand filling capacity. Two new filling lines are currently being designed for Vetter's Ravensburg South facility in Germany. The new lines will fill liquid cartridges and vials and will add to the production site’s current lines, one of which is a syringe line that was launched in the spring 2013. At Vetter’s US clinical manufacturing facility in Chicago, a third filling line for prefilled syringes is nearing completion. Expected to be operational in 2014, the new clinical line will have a maximum batch size of 30,000.

To enhance efficiency in up-and downstream processes but also to accommodate the additional capacity, Vetter is expanding its storage volume for cold-and room-temperature products as well as frozen products. In addition, two new thawing rooms in Class 100,000 environment and two more lyophilizers to add to the currently nine in operation, will be installed. Also, Vetter’s single-use isolator technology is being expanded and implemented at Vetter production facilities to lower risk of product cross-contamination with high-potent compounds, such as hormones and cancer therapeutics.

Source: Vetter

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here